The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Silk-based biomaterials for sustained drug delivery
Open accessAbstract
Silk presents a rare combination of desirable properties for sustained drug delivery, including aqueous-based purification and processing options without chemical cross-linkers, compatibility with common sterilization methods, controllable and surface-mediated biodegradation into non-inflammatory by-products, biocompatibility, utility in drug stabilization, and robust mechanical properties. A versatile silk-based toolkit is currently available for sustained drug delivery formulations of small molecule through macromolecular drugs, with a promise to mitigate several drawbacks associated with other degradable sustained delivery technologies in the market. Silk-based formulations utilize silk’s well-defined nano- through microscale structural hierarchy, stimuli-responsive self-assembly pathways and crystal polymorphism, as well as sequence and genetic modification options towards targeted pharmaceutical outcomes. Furthermore, by manipulating the interactions between silk and drug molecules, near-zero order sustained release may be achieved through diffusion- and degradation-based release mechanisms. Because of these desirable properties, there has been increasing industrial interest in silk-based drug delivery systems currently at various stages of the developmental pipeline from pre-clinical to FDA-approved products. Here, we discuss the unique aspects of silk technology as a sustained drug delivery platform and highlight the current state of the art in silk-based drug delivery. We also offer a potential early development pathway for silk-based sustained delivery products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Stabilization of vaccines and antibiotics in silk and eliminating the cold chain
Zhang, J., Pritchard, E., Hu, X., Valentin, T., Panilaitis, B., Omenetto, F. G., & Kaplan, D. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206210109 · Cited by 168
Self-citationRetractedRitger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90035-6 · Cited by 4,064
Hydrogels in pharmaceutical formulations
Peppas, N. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00090-4 · Cited by 4,011
Ritger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90034-4 · Cited by 3,830
Altman, G. H., Diaz, F., Jakuba, C., Calabro, T., Horan, R. L., Chen, J., Lu, H., Richmond, J., & Kaplan, D. L. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00353-8 · Cited by 3,458
Self-citationBiodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Materials fabrication from Bombyx mori silk fibroin
Rockwood, D. N., Preda, R. C., Yücel, T., Wang, X., Lovett, M. L., & Kaplan, D. L. (2011) · Nature Protocols · doi:10.1038/nprot.2011.379 · Cited by 3,066
Self-citationAnalysis of Fickian and non-Fickian drug release from polymers.
Peppas, N. A. (1985) · PubMed · Cited by 2,139
Hydrogels in controlled release formulations: Network design and mathematical modeling
Lin, C.-C., & Metters, A. T. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.004 · Cited by 1,768
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Cited by
Design of biodegradable, implantable devices towards clinical translation
Li, C., Guo, C., Fitzpatrick, V., Ibrahim, A., Zwierstra, M. J., Hanna, P., Lechtig, A., Nazarian, A., Lin, S. J., & Kaplan, D. L. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0150-z · Cited by 808
Self-citationRecent approaches in designing bioadhesive materials inspired by mussel adhesive protein
Kord Forooshani, P., & Lee, B. P. (2017) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.28368 · Cited by 632
Silk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Stewart, S. A., Domínguez-Robles, J., Donnelly, R. F., & Larrañeta, E. (2018) · Polymers · doi:10.3390/polym10121379 · Cited by 390
Recent trends in protein and peptide-based biomaterials for advanced drug delivery
Varanko, A., Saha, S., & Chilkoti, A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.008 · Cited by 369
Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside
Chouhan, D., & Mandal, B. B. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.050 · Cited by 348
Silk Fibroin-Based Nanoparticles for Drug Delivery
Zhao, Z., Li, Y., & Xie, M.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034880 · Cited by 332
Thiol–ene Click Hydrogels for Therapeutic Delivery
Kharkar, P. M., Rehmann, M. S., Skeens, K. M., Maverakis, E., & Kloxin, A. M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00420 · Cited by 258
Shen, X., Zhang, Y., Gu, Y., Xu, Y., Liu, Y., Li, B., & Chen, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.023 · Cited by 253
A review on mechanical considerations for chronically-implanted neural probes
Lecomte, A., Descamps, E., & Bergaud, C. (2018) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa8b4f · Cited by 205
Controlled release of cytokines using silk-biomaterials for macrophage polarization
Reeves, A. R. D., Spiller, K. L., Freytes, D. O., Vunjak-Novakovic, G., & Kaplan, D. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.027 · Cited by 131
Self-citationLecomte, A., Castagnola, V, Descamps, E., Dahan, L., Blatché, M. C., Dinis, T. M., Leclerc, E., Egles, C., & Bergaud, C. (2015) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/25/12/125003 · Cited by 110
Drug release from core-shell PVA/silk fibroin nanoparticles fabricated by one-step electrospraying
Cao, Y., Liu, F., Chen, Y., Yu, T., Lou, D., Guo, Y., Li, P., Wang, Z., & Ran, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12351-1 · Cited by 104
Kaushik, S., Thungon, P. D., & Goswami, P. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01971 · Cited by 69
Gulati, S., Ansari, N., Moriya, Y., Joshi, K., Prasad, D., Sajwan, G., Shukla, S., Kumar, S., & Varma, R. S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00599f · Cited by 52
Chaturvedi, V., Naskar, D., Kinnear, B. F., Grenik, E., Dye, D. E., Grounds, M. D., Kundu, S. C., & Coombe, D. R. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2227 · Cited by 50
“Silk proteins are used in implantable biomaterials, drug delivery vehicles and medical devices (Omenetto and Kaplan, 2010; Kundu et al., 2013, Yucel et al., 2014).”
BackgroundLithium-free processing of silk fibroin
Zheng, Z., Guo, S., Liu, Y., Wu, J., Li, G., Liu, M., Wang, X., & Kaplan, D. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216653259 · Cited by 45
Self-citationWafer-Scale Multilayer Fabrication for Silk Fibroin-Based Microelectronics
Kook, G., Jeong, S., Kim, S. H., Kim, M. K., Lee, S., Cho, I.-J., Choi, N., & Lee, H. J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b13170 · Cited by 28
Metadata
- Authors
- Yucel, T., Lovett, M. L., & Kaplan, D. L.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 381-397
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1989728410
- Cited by
- 359
- References
- 151
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.